Biomaterials have long been explored in regenerative medicine strategies for repair or replacement of damaged organs and tissues. However, poor adhesion under wet conditions (like those found in tissues) has thus far limited their wider application. Indeed, despite its favourable physicochemical properties, facile gelation and biocompatibility, gellan gum (GG)-based hydrogels lack the tissue adhesiveness required for effective clinical use. Aiming at assessing whether substitution of GG by dopamine (DA) could be a suitable approach to overcome this problem, database searches were conducted on PubMed® and Embase® up to 02 March 2021, for studies using biomaterials covalently modified with a catechol-containing substituent conferring improved adhesion properties. In this regard, a total of 47 reports (out of 700 manuscripts, ~ 6.7%) were found to comply with the search/selection criteria, the majority of which (34/47, ~ 72%) describing modification of natural polymers, such as chitosan (11/47, ~ 23%) and hyaluronic acid (6/47, ~ 13%); conjugation of dopamine (as catechol “donor”) via carbodiimide coupling chemistry was also predominant. Overall, there is ample literature evidence that bio-inspired substitution of polymers of natural and synthetic origin by DA or other catechol moieties greatly improves adhesion to biological tissues.
Modified Polymer |
Substituent/ Coupling Chemistry |
Crosslinking Mechanism/ Catalyst |
Adhesive Strength | Reported Features/Findings | Intended Application |
Ref. |
---|---|---|---|---|---|---|
Poly(ethyleneglycol) | DA/NHS-mediated amine-reactive chemistry | Oxidative/NaIO4 | 8 kPa |
|
Tissue engineering and drug delivery | [45] |
L-DOPA/carbodiimide chemistry | N.A. | 50 ng/cm2 (mucoadsorption) and 356.108 pN (pull-off force) |
|
Drug delivery | [46] | |
L-DOPA/carbodiimide chemistry | Oxidative/NaIO4 | 35 ± 12.5 kPa |
|
Tissue adhesive | [47] | |
DA/Michael Reaction | Photo-mediated (UV light) | 6.1 ± 0.5 MPa |
|
Tissue adhesive | [48] | |
Prepolymerised allyl 2-cyanoacrylate | L-DOPA or DA/N.A. | Chemical (Michael addition) | 0.71 ± 0.04 MPa |
|
Bio-glue | [49] |
Poly(dopamine methacrylamide-co-Methoxyethyl acrylate) | DA/Messersmith’s method | Ionic/CaSO4 and MgSO4 | 165 ± 13.5 kPa |
|
Tissue adhesive | [50] |
Pluronic F127 | DA/activation by p-NPC and reaction with DETA or TETA |
Chemical (Michael addition) | 13.7 ± 1.6 kPa |
|
Tissue adhesive | [51] |
Recombinant fp-1 (rfp-1) mussel adhesive protein | L-DOPA/enzymatic reaction (tyrosinase) | Oxidative or Ionic/NaIO4 or Fe3+ | 200 kPa (ox. gelation) and 130 kPa (ionic gelation) |
|
Tissue adhesive | [52] |
Thiourea-linked monoacrylated β-cyclodextrins | Catechol-RGD/post-gelation functionalisation via thiourea-catechol coupling reaction | Photo-mediated (UV light) | 2.0 kPa |
|
Tissue adhesive and sealant | [53] |
Polymethacrylic acid | L-DOPA, carbodiimide chemistry | Solvent exchange | 1780 mJ/m2 |
|
Tissue adhesive | [54] |
Ureido-pyrimidinone | DA/HATU chemistry | Solvent casting (films) | 170.9 ± 13.4 cell/mm2 |
|
Cell therapy, tissue engineering | [55] |
Polyacrylic acid and alginic acid | Adenine-DA/carbodiimide chemistry | Oxidative/Ammonium persulfate | 200 g.s |
|
Tissue adhesive | [56] |
Elastin-derived polypeptides | DA/carbodiimide chemistry | Oxidative/NaIO4 | 37 kPa |
|
Wound healing and wound dressing | [57] |